Skip to content
Friday, November 20, 2026
Responsive Menu
Home
Healthcare Newsdesk
The Latest UK Healthcare News brought to you by NTSI
Search
Search
Home
Care Home News
Carers
Medicine & Clinical Practice
Arthritis
Brain Conditions
Cancer
Colds and Flu
Diabetes
Diet & Exercise
Eyecare
Menopause
Mens Health
Mental Wellbeing
Psychology
Rare Medical Conditions
Smoking
Women’s Health
Physiotherapy
Private Practice
Recruitment
Wellbeing at Work
Home
Clinical News
Protecting against brain damage by improving treatment in neonates with hypoglycaemia: ProBrain-D–a study protocol of a prospective longitudinal study
Clinical News
Protecting against brain damage by improving treatment in neonates with hypoglycaemia: ProBrain-D–a study protocol of a prospective longitudinal study
August 19, 2022
Articles From The BMJ
Post navigation
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomised controlled trials
Scoping review of models and frameworks of patient engagement in health services research